1. Home
  2. CELU vs MKZR Comparison

CELU vs MKZR Comparison

Compare CELU & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • MKZR
  • Stock Information
  • Founded
  • CELU 2016
  • MKZR 2012
  • Country
  • CELU United States
  • MKZR United States
  • Employees
  • CELU N/A
  • MKZR N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • MKZR
  • Sector
  • CELU Health Care
  • MKZR
  • Exchange
  • CELU Nasdaq
  • MKZR Nasdaq
  • Market Cap
  • CELU 50.4M
  • MKZR 56.6M
  • IPO Year
  • CELU N/A
  • MKZR N/A
  • Fundamental
  • Price
  • CELU $2.30
  • MKZR $2.41
  • Analyst Decision
  • CELU
  • MKZR
  • Analyst Count
  • CELU 0
  • MKZR 0
  • Target Price
  • CELU N/A
  • MKZR N/A
  • AVG Volume (30 Days)
  • CELU 89.6K
  • MKZR 97.8K
  • Earning Date
  • CELU 12-06-2024
  • MKZR 01-01-0001
  • Dividend Yield
  • CELU N/A
  • MKZR 7.26%
  • EPS Growth
  • CELU N/A
  • MKZR N/A
  • EPS
  • CELU N/A
  • MKZR N/A
  • Revenue
  • CELU $48,200,000.00
  • MKZR $17,563,335.00
  • Revenue This Year
  • CELU N/A
  • MKZR N/A
  • Revenue Next Year
  • CELU $233.89
  • MKZR N/A
  • P/E Ratio
  • CELU N/A
  • MKZR N/A
  • Revenue Growth
  • CELU 225.94
  • MKZR N/A
  • 52 Week Low
  • CELU $1.30
  • MKZR $1.05
  • 52 Week High
  • CELU $7.97
  • MKZR $5.50
  • Technical
  • Relative Strength Index (RSI)
  • CELU 52.94
  • MKZR N/A
  • Support Level
  • CELU $2.04
  • MKZR N/A
  • Resistance Level
  • CELU $2.39
  • MKZR N/A
  • Average True Range (ATR)
  • CELU 0.17
  • MKZR 0.00
  • MACD
  • CELU 0.02
  • MKZR 0.00
  • Stochastic Oscillator
  • CELU 70.76
  • MKZR 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.

Share on Social Networks: